News

News
FDA – Waives Clinical Efficacy Studies
Biosimlar Assessment Service. 3d render of several similar antibodies

FDA – Waives Clinical Efficacy Studies

A New Era for Biosimilars: Powered by Analytics In a historic regulatory shift, the U.S....

A holistic analysis platform for assessing protein modification and functional activity

Linking Protein Modifications to Functional Impact. Protein modifications are critical for the efficacy, safety, and...

Midas Pharma and Biofidus join forces for integrated Biotech Solutions

Biofidus AG is now a member of the Midas group. With the acquisition of Biofidus,...

GDPR Cookie Consent with Real Cookie Banner